Aceragen Stock Price, News & Analysis
Company Description
Aceragen (NASDAQ: ACGN) is a publicly traded biological product (except diagnostic) manufacturing company in the Manufacturing sector.
ACGN stock has declined 100.0% over the past year.
This page provides a comprehensive overview of ACGN stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Aceragen (ACGN) stock. Over the past 12 months, the stock has lost 100.0%.
Latest News
Aceragen has 3 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 2 with negative movement. View all ACGN news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ACGN Company Profile & Sector Positioning
Aceragen (ACGN) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.